References
- Ferlay J et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. Lyon, France: International Agency for Research on Cancer, 2013. IARC CancerBase No. 11. Accessed Jun 2016. Available at: http://publications.iarc.fr/Databases/Iarc-Cancerbases/Globocan-2012-Estimated-Cancer-Incidence-Mortality-And-Prevalence-Worldwide-In-2012-V1-0-2012
- World Health Organization. Human papillomavirus (HPV) and cervical cancer. Available at: http://www.who.int/mediacentre/factsheets/fs380/en/, Accessed Jun 2016.
- American Cancer Society. Cancer Facts and Figures 2016. Atlanta, Ga: American Cancer Society. Accessed Jun 2016. Available at: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf
- Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de Sanjosé S, Castellsagué X. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health 2016; 4:e453-63; PMID:27340003; https://doi.org/10.1016/S2214-109X(16)30099-7
- Bailey HH, Chuang LT, duPont NC, Eng C, Foxhall LE, Merrill JK, Wollins DS, Blanke CD. American society of clinical oncology statement: human papillomavirus vaccination for cancer prevention. J Clin Oncol 2016; 34:1803-12; PMID:27069078; https://doi.org/10.1200/JCO.2016.67.2014
- Larson HJ, Wilson R, Hanley S, Parys A, Paterson P. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation. Hum Vaccin Immunother 2014; 10:2543-50; PMID:25483472; https://doi.org/10.4161/21645515.2014.969618
- Japanese Ministry of Health, Labour and Welfare. Correspondence about the routine vaccination of human papilloma virus infection (recommendation). Accessed Jun 2016. Available at: http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou28/pdf/kankoku_h25_6_01.pdf
- Ueda Y, Enomoto T, Sekine M, Egawa-Takata T, Morimoto A, Kimura T. Japan's failure to vaccinate girls against human papillomavirus. Am J Obstet Gynecol 2015; 212:405-6; PMID:25434842; https://doi.org/10.1016/j.ajog.2014.11.037
- Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet 2015; 385:2571; PMID:26122153; https://doi.org/10.1016/S0140-6736(15)61152-7
- Sekine M et al. Japanese Crisis of HPV Vaccination. Int J Pathol Clin Res, IJPCR-2-039, (Volume 2, Issue 2), ISSN: 2469-5807, 2016.
- Larson HJ, Wilson R, Hanley S, Parys A, Paterson P. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation. Hum Vaccin Immunother 2014; 10:2543-50; PMID:25483472; https://doi.org/10.4161/21645515.2014.969618
- World Health Organization. GACVS Statement on Safety of HPV vaccines - 17 December 2015. Accessed Jun 2016. Available at: http://www.who.int/vaccine_safety/committee/GACVS_HPV_statement_17Dec2015.pdf
- Matsuda A, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H; Japan Cancer Surveillance Research Group. Japan Cancer Surveillance Research Group : Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2013; 43:328-36; PMID:23296772; https://doi.org/10.1093/jjco/hys233
- Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer 2013; 49:3262-73; PMID:23751569; https://doi.org/10.1016/j.ejca.2013.04.024
- OECD. OECD Health Data 2013. June 2013.
- Japanese Ministry of Health, Labour and Welfare. Consultation situation of cancer screening, Comprehensive Survey of Living Conditions 2010. Accessed Jun 2016. Available at: http://www.mhlw.go.jp/stf/houdou/2r9852000001igt0.html
- Tanaka Y, Ueda Y, Egawa-Takata T, Yagi A, Yoshino K, Kimura T. Outcomes for girls without HPV vaccination in Japan. Lancet Oncol 2016; 17:868-9; PMID:27396634; https://doi.org/10.1016/S1470-2045(16)00147-9
- Ozawa N, Ito K, Tase T, Metoki H, Yaegashi N. Beneficial Effects of human papillomavirus vaccine for prevention of cervical abnormalities in Miyagi, Japan. Tohoku J Exp Med 2016; 240:147-51; https://doi.org/10.1620/tjem.240.147
- Tanaka Y, Ueda Y, Kimura T. Struggles within Japan's national HPV vaccination: a proposal for future strategy. Hum Vaccin Immunother 2017 Jan 6:0; [ Epub ahead of print]; https://doi.org/10.1080/21645515.2016.1267085